Human T-Lymphotropic Virus Type 1: (HTLV-1)

Introduction

This section will include an overview of the virus including history and current research

The human T-lymphotropic virus type 1 (HTLV-1) was the first oncogenic human retrovirus to be discovered. It was first studied in 1977. The virus can cause adult T-cell leukemia/lymphoma (ATL) and progressive nervous system condition known as HTLV-1-associated myelopathy or tropical spastic paraparesis (HAM/TSP)along with other neurodegenerative diseases. Although HTLV is known for being associated with lymphoma and leukemia, it more commonly causes a range of neurological disorders due to the types of cells that are infected. Human T-Lymphotropic Virus can attack a variety of cells including T cells, B cells, dendritic cells, monocytes, and endothelial cells but this virus can only edit or transform T cells and B cells. This transformation is what causes cancer in rare cases. HTLV is most commonly associated with Tropical spastic paraparesis.Tropical spastic paraparesis (TSP), is a medical condition that causes weakness, muscle spasms, and sensory disturbance resulting in weakness of the legs. However, most HTLV carriers are asymptomatic and transmit the virus to others. HTLV type 1 is less commonly associated with B cell chronic lymphocytic leukemia and T-prolymphocytic leukemia.

Structure

This section will include the structure of the virus

Human T-Lymphotropic Virus is part of the Delta-type retrovirus group. HTLVs are enveloped viruses with a diameter of approximately 80–100 nm. The HTLV virions contain two covalently bound genomic RNA strands, which are complexed with the viral enzymes reverse transcriptase, integrase and protease, and the capsid proteins. The outer part of the virions consists of a membrane-associated matrix protein and a lipid layer intersected by the envelope proteins. The viral genome

Life Cycle

This section will include life cycle of the virus, replication, and how it infects cells

Shows how the virus enters the cell and infects[1].

Diagnosis

This section will include the diagnosis process of this oncogenic virus and symptoms of the infection

This map shows areas of the world where HTLV-1 is commonly diagnosed. Note that the areas are not divided by country, just the specific areas where HTLV has the most effects.[2].

Treatment

This section will include treatment and living with the virus and the affects of the symptoms caused by the virus

Conclusion

This section will include a summary

Overall text length should be at least 1,000 words (before counting references), with at least 2 images. Include at least 5 references under Reference section.

Edited by [Sydney Srnka], student of Joan Slonczewski for BIOL 116 Information in Living Systems, 2020, Kenyon College.